Kiwi Biosciences
BostonFounded 202010+ employeesPrivate
$1.6M raisedSeed· last: seed (Oct 2021)· 2 rounds
Backed by(6 investors)
Acacia Venture Capital PartnersEmily LeproustJude GomilaNorth South VenturesSURF IncubatorY Combinator
Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.
